These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1641524)

  • 1. Oestriol in the prophylactic treatment of recurrent urinary tract infections in postmenopausal women.
    Kirkengen AL; Andersen P; Gjersøe E; Johannessen GR; Johnsen N; Bodd E
    Scand J Prim Health Care; 1992 Jun; 10(2):139-42. PubMed ID: 1641524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections.
    Raz R; Stamm WE
    N Engl J Med; 1993 Sep; 329(11):753-6. PubMed ID: 8350884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low dose oestrogen prophylaxis for recurrent urinary tract infections in elderly women.
    Cardozo L; Benness C; Abbott D
    Br J Obstet Gynaecol; 1998 Apr; 105(4):403-7. PubMed ID: 9609266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of estriol on the cytology of urethra and vagina in postmenopausal women with genito-urinary symptoms.
    van der Linden MC; Gerretsen G; Brandhorst MS; Ooms EC; Kremer CM; Doesburg WH
    Eur J Obstet Gynecol Reprod Biol; 1993 Sep; 51(1):29-33. PubMed ID: 8282140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oestriol in the treatment of postmenopausal urgency: a multicentre study.
    Cardozo L; Rekers H; Tapp A; Barnick C; Shepherd A; Schussler B; Kerr-Wilson R; van Geelan J; Barlebo H; Walter S
    Maturitas; 1993 Dec; 18(1):47-53. PubMed ID: 8107615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of estriol-containing vaginal pessaries and nitrofurantoin macrocrystal therapy in the prevention of recurrent urinary tract infection in postmenopausal women.
    Raz R; Colodner R; Rohana Y; Battino S; Rottensterich E; Wasser I; Stamm W
    Clin Infect Dis; 2003 Jun; 36(11):1362-8. PubMed ID: 12766829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral oestriol on vaginal flora and cytology and urogenital symptoms in the post-menopause.
    Molander U; Milsom I; Ekelund P; Mellström D; Eriksson O
    Maturitas; 1990 Jun; 12(2):113-20. PubMed ID: 2255263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women.
    Eriksen B
    Am J Obstet Gynecol; 1999 May; 180(5):1072-9. PubMed ID: 10329858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of an ultra-low-dose 0.005 % estriol vaginal gel in the prevention of urinary tract infections in postmenopausal women with genitourinary syndrome of menopause: A randomized double-blind placebo-controlled trial.
    Muiños Fernández N; Martínez Salamanca JI; Pardo González de Quevedo JI; Diz Morales MP; Palomo Alameda L; Duce Tello S; González Béjar M; Rabanal Carrera A; Rosado Martín J; Noguera Vera L; Doyle Sanchez A; Rodríguez Mariblanca A; García Aguilar E
    Maturitas; 2024 Sep; 190():108128. PubMed ID: 39388913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing Recurrent Urinary Tract Infections in Postmenopausal Women.
    Seaberg P; Jadoon-Khamash E; Vegunta S
    J Womens Health (Larchmt); 2018 Jul; 27(7):856-858. PubMed ID: 30020847
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of an orally administered combination of hyaluronic acid, chondroitin sulfate, curcumin and quercetin for the prevention of recurrent urinary tract infections in postmenopausal women.
    Torella M; Del Deo F; Grimaldi A; Iervolino SA; Pezzella M; Tammaro C; Gallo P; Rappa C; De Franciscis P; Colacurci N
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():125-128. PubMed ID: 27838537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women.
    Dessole S; Rubattu G; Ambrosini G; Gallo O; Capobianco G; Cherchi PL; Marci R; Cosmi E
    Menopause; 2004; 11(1):49-56. PubMed ID: 14716182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postcoital antimicrobial prophylaxis for recurrent urinary tract infection. A randomized, double-blind, placebo-controlled trial.
    Stapleton A; Latham RH; Johnson C; Stamm WE
    JAMA; 1990 Aug; 264(6):703-6. PubMed ID: 2197450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oestradiol-releasing vaginal ring versus oestriol vaginal pessaries in the treatment of bothersome lower urinary tract symptoms.
    Lose G; Englev E
    BJOG; 2000 Aug; 107(8):1029-34. PubMed ID: 10955437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial.
    Hopkins WJ; Elkahwaji J; Beierle LM; Leverson GE; Uehling DT
    J Urol; 2007 Apr; 177(4):1349-53; quiz 1591. PubMed ID: 17382730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of combined treatment with phenylpropanolamine and estriol, compared with estriol treatment alone, in postmenopausal women with stress urinary incontinence.
    Ahlström K; Sandahl B; Sjöberg B; Ulmsten U; Stormby N; Lindskog M
    Gynecol Obstet Invest; 1990; 30(1):37-43. PubMed ID: 2227611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of live lactobacilli in combination with low dose oestriol (Gynoflor) to restore the vaginal flora after treatment of vaginal infections.
    Ozkinay E; Terek MC; Yayci M; Kaiser R; Grob P; Tuncay G
    BJOG; 2005 Feb; 112(2):234-40. PubMed ID: 15663590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy.
    Palacios S; Castelo-Branco C; Cancelo MJ; Vázquez F
    Maturitas; 2005 Feb; 50(2):98-104. PubMed ID: 15653006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dose estriol pessaries for the treatment of vaginal atrophy: a double-blind placebo-controlled trial investigating the efficacy of pessaries containing 0.2mg and 0.03mg estriol.
    Griesser H; Skonietzki S; Fischer T; Fielder K; Suesskind M
    Maturitas; 2012 Apr; 71(4):360-8. PubMed ID: 22285095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase 2 clinical trial of a vaginal mucosal vaccine for urinary tract infections.
    Uehling DT; Hopkins WJ; Elkahwaji JE; Schmidt DM; Leverson GE
    J Urol; 2003 Sep; 170(3):867-9. PubMed ID: 12913718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.